20% Higher Sales, 20% Lower Costs: How Axtria MarketingIQ™ Maximizes Brand Growth of an Anti-Diabetic Drug

Despite having a large budget, pharmaceutical companies struggle with effective marketing execution, as they often lack visibility into the most effective channels and precise targeting strategies. Fragmented data and a reliance on external agencies lead to reactive spending and inefficiencies in optimal resource utilization.

The result? Their brands don’t reach their growth potential, and companies aren’t able to make the best of ROI from their spending.

A company wrestling with these challenges came to Axtria. In this case study, you’ll see how Axtria maximized brand growth through a multi-phased approach, helping the company streamline its workflows, scale technology, boost sales, and reduce costs to support geographic expansion.
Some of the highlights of Axtria’s solution included:

• Data-Driven Channel Prioritization: Analytics-driven insights to focus promotional efforts on the most effective channels.
• Sales Force Reallocation: Shifted focus to specialists, boosting prescription performance without expanding the team.
• High-Impact Event Planning: Reallocated event budgets based on attendee count, event format, and impact, driving sales and effectiveness.
• Impactful Email Strategy: Balanced approach to email outreach with personalized strategy driving higher engagement.

Download the detailed case study to learn more, and get in touch with us at connect@axtria.com for more insights about this solution.